The HPRA advises healthcare professionals not to retain printed versions of Summary of Product Characteristics (SPC) documents. As these documents are subject to frequent content updates, including changes to safety and dose related information, we recommend that you visit our website as necessary to access the most up-to-date versions. If you have any queries about specific SPCs on our website then please e-mail info@hpra.ie


Akynzeo 300 mg/0.5 mg hard capsules



Helsinn Birex Pharmaceuticals LimitedEU/1/15/1001/001

Main Information

Trade NameAkynzeo 300 mg/0.5 mg hard capsules
Active SubstancesNetupitant
Palonosetron (as hydrochloride)
Dosage FormCapsule, hard
Licence HolderHelsinn Birex Pharmaceuticals Limited
Licence NumberEU/1/15/1001/001

Group Information

ATC CodeA04AA Serotonin (5HT3) antagonists
A04AA05 palonosetron

Status

Authorised/WithdrawnAuthorised
Licence Issued27/05/2015
Legal statusProduct subject to prescription which may not be renewed (A)
Supply StatusSupply through pharmacies only
Advertising StatusAdvertising to healthcare professionals only
Conditions of Licence
Marketing StatusUnknown

Documents

Summary of Product CharacteristicsSearch EMA website
Package LeafletSearch EMA website
Public Assessment ReportSearch EMA website
« Back